Exact Therapeutics (Norway) Probability of Future Stock Price Finishing Over 3.78
| EXTX Stock | NOK 3.78 0.06 1.56% |
Exact |
Exact Therapeutics Target Price Odds to finish over 3.78
The tendency of Exact Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.78 | 90 days | 3.78 | close to 99 |
Based on a normal probability distribution, the odds of Exact Therapeutics to move above the current price in 90 days from now is close to 99 (This Exact Therapeutics AS probability density function shows the probability of Exact Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Exact Therapeutics has a beta of 0.31 suggesting as returns on the market go up, Exact Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Exact Therapeutics AS will be expected to be much smaller as well. Additionally Exact Therapeutics AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Exact Therapeutics Price Density |
| Price |
Predictive Modules for Exact Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Exact Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Exact Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Exact Therapeutics is not an exception. The market had few large corrections towards the Exact Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Exact Therapeutics AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Exact Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.46 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 0.57 | |
Ir | Information ratio | -0.1 |
Exact Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Exact Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Exact Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Exact Therapeutics generated a negative expected return over the last 90 days | |
| Exact Therapeutics has high historical volatility and very poor performance | |
| Exact Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (58.59 M) with profit before overhead, payroll, taxes, and interest of 52 K. | |
| Exact Therapeutics generates negative cash flow from operations | |
| About 64.0% of the company shares are held by company insiders |
Exact Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Exact Stock often depends not only on the future outlook of the current and potential Exact Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Exact Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30 M | |
| Shares Float | 10.3 M |
Exact Therapeutics Technical Analysis
Exact Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Exact Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Exact Therapeutics AS. In general, you should focus on analyzing Exact Stock price patterns and their correlations with different microeconomic environments and drivers.
Exact Therapeutics Predictive Forecast Models
Exact Therapeutics' time-series forecasting models is one of many Exact Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Exact Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Exact Therapeutics
Checking the ongoing alerts about Exact Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Exact Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Exact Therapeutics generated a negative expected return over the last 90 days | |
| Exact Therapeutics has high historical volatility and very poor performance | |
| Exact Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (58.59 M) with profit before overhead, payroll, taxes, and interest of 52 K. | |
| Exact Therapeutics generates negative cash flow from operations | |
| About 64.0% of the company shares are held by company insiders |
Other Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.